Medical Innovation
AI in medicine, gene therapy, longevity science, and the frontiers of clinical research.
148 articles

Septic Shock Resuscitation: Updated Fluid, Vasopressor, and Bundle Evidence in 2025
Clinical guide to septic shock resuscitation — the SMART trial crystalloid evidence, vasopressor selection, the 30mL/kg mandate controversy, and Hour-1 Bundle implementation in hospital settings.
Jun 28, 2026
Acute Kidney Injury in Hospitalized Patients: Prevention, Recognition, and Management
Clinical guide to hospital-acquired AKI — KDIGO staging, prevention of contrast nephropathy and nephrotoxic drug AKI, recognition of AKI in post-surgical and ICU patients, and management principles.
Jun 20, 2026
Xenotransplantation in 2026: Genetically Edited Pig Organs Are Saving Human Lives
After decades of false starts, genetically modified pig kidneys and hearts are being transplanted into living patients with remarkable early results. Here's what the science shows — and what it means for the organ shortage crisis.
Jun 18, 2026
SIBO and IBS: Hydrogen Breath Testing, Clinical Diagnosis, and Evidence-Based Treatment
Complete clinical guide to small intestinal bacterial overgrowth — hydrogen and methane breath testing, diagnostic accuracy, rifaximin treatment evidence, and the IBS-SIBO relationship.
Jun 18, 2026
Lecanemab vs. Donanemab: The Race to Slow Alzheimer's Disease in 2026
Two FDA-approved amyloid-clearing antibodies are rewriting the Alzheimer's treatment landscape. We break down the head-to-head data, ARIA risk profiles, and what real-world use looks like two years into the post-approval era.
Jun 15, 2026
CRISPR Delivers a One-Time Cure for Hereditary Angioedema: What the 2026 Data Shows
NTLA-2002, the CRISPR-based gene editing therapy for hereditary angioedema, has achieved near-complete attack elimination in Phase III trials with a single injection. This may be the clearest proof yet that CRISPR can cure genetic disease.
Jun 12, 2026
AI Diagnostics in Primary Care: How Machine Learning Is Detecting Disease Earlier Than Ever
From AI-powered ECG interpretation to retinal scans that predict cardiovascular risk, machine learning is giving primary care physicians superhuman diagnostic capability at point-of-care.
Jun 12, 2026
AI Ambient Documentation in Clinical Practice: Reducing Physician Burnout Through Automated Notes
How AI ambient clinical intelligence tools (Nuance DAX, Suki, Abridge) are transforming physician documentation workflows, reducing after-hours EHR time, and early evidence on burnout reduction.
Jun 10, 2026
CRISPR Gene Therapy in 2025: From Lab Breakthrough to Real Patients
After years of promise, CRISPR therapies are delivering landmark results in sickle cell disease, transthyretin amyloidosis, and cancer immunotherapy. Here's the clinical scorecard.
Jun 8, 2026
Antibiotic Stewardship: Evidence-Based Program Implementation and Resistance Prevention in 2025
Clinical guide to antibiotic stewardship programs — the evidence that ASPs reduce resistance and adverse effects, core stewardship interventions (prospective audit and feedback, de-escalation), and metrics for program success.
Jun 4, 2026
Sepsis Early Recognition: Updated Protocols, Biomarkers, and Bundle Compliance in 2025
Evidence-based clinical review of sepsis early recognition strategies — qSOFA vs. SOFA, lactate, procalcitonin, and the SEP-1 bundle compliance requirements for hospital accreditation.
Jun 2, 2026
Alzheimer's New Treatments: Lecanemab and Donanemab — What They Mean for Patients
After decades of failed trials, two amyloid-clearing antibodies have demonstrated statistically significant slowing of Alzheimer's disease progression. The era of disease-modifying therapy has arrived — with important caveats.
Jun 2, 2026
GLP-1 Receptor Agonists in Obesity Medicine: Semaglutide, Tirzepatide & the Clinical Evidence
Semaglutide and tirzepatide have produced the most dramatic weight loss outcomes in pharmaceutical history. This clinical guide covers mechanisms, patient selection, monitoring, and supply implications.
Jun 1, 2026
The Antibiotic Resistance Crisis: What Clinicians Must Know in 2025
AMR kills 1.27 million people per year globally — more than HIV/AIDS or malaria. New resistance mechanisms, dwindling pipelines, and practical stewardship strategies for healthcare facilities.
May 30, 2026
Telehealth After COVID: Which Models Stuck, Which Failed, and Where Virtual Care Goes Next
Telehealth utilization exploded 3,000% during COVID and has settled at roughly 10× pre-pandemic levels. Five years of data now reveal which clinical use cases work well virtually and which don't.
May 28, 2026
Cardiac Rehabilitation: Evidence, Utilization Gaps, and Clinical Benefits After MI and Heart Failure
Evidence-based guide to cardiac rehabilitation — survival benefits post-MI and heart failure, the significant utilization gap, supervised vs. home-based CR, and barriers to enrollment and completion.
May 27, 2026
mRNA Technology Beyond COVID: Cancer Vaccines, Flu, RSV, and the Future Pipeline
The COVID-19 pandemic validated mRNA vaccine technology at unprecedented scale. Now that platform is being turned toward cancer, influenza, CMV, and dozens of other targets.
May 20, 2026
CKD Progression Management in 2025: SGLT2 Inhibitors, Finerenone, and the New Standard of Care
Evidence-based guide to slowing CKD progression — SGLT2 inhibitor renoprotection, finerenone in CKD-T2DM, GFR monitoring, and the paradigm shift in CKD management.
May 19, 2026
Prostate Cancer Screening in 2025: PSA Testing, MRI, and the Overtreatment Debate
After years of controversy, prostate cancer screening guidelines are converging — recommending PSA testing for men 55–69 after informed discussion, with MRI dramatically improving diagnostic precision.
May 18, 2026
Microplastics & Human Health: What the Evidence Shows and Supply Chain Implications
Microplastics have been found in human blood, lungs, placenta, and breast milk. This guide covers the health evidence, regulatory landscape, and implications for healthcare supply selection.
May 16, 2026
CAR-T Cell Therapy Expansion: New Targets, Earlier Lines, and the Next Generation
CAR-T therapy has transformed outcomes in B-cell malignancies and multiple myeloma. Five new approvals since 2021 and a pipeline targeting solid tumors represent the next chapter.
May 15, 2026
Telehealth & Remote Patient Monitoring in 2025: Clinical Evidence and Supply Requirements
Telehealth visits have stabilized at 15–20% of all outpatient care. Remote patient monitoring (RPM) for chronic disease management has accumulated strong evidence. Here's the clinical and supply picture.
May 12, 2026
Hospital Fall Prevention in 2025: Multifactorial Interventions and Technology-Enhanced Surveillance
Evidence-based update on inpatient fall prevention — multifactorial risk assessment, bed alarms debate, video surveillance, medication review, and falls costs to healthcare systems.
May 12, 2026
Long COVID Clinical Management: Evidence for Post-COVID Syndrome Mechanisms and Treatment in 2025
Clinical guide to Long COVID — proposed mechanisms (viral persistence, autoimmunity, microbiome disruption), evidence-based management of fatigue/PEM, cognitive dysfunction, and dysautonomia, and emerging trial data.
May 11, 2026
Psilocybin Therapy in 2026: FDA Status, Clinical Evidence, and What's Happening After Australia Led the Way
Australia became the first country to prescribe psilocybin for treatment-resistant depression and MDMA for PTSD in July 2023. In 2026, FDA decisions on both compounds are pending, clinical trials continue to show dramatic efficacy, and a regulated therapy infrastructure is emerging.
May 10, 2026
Long COVID in 2025: Mechanisms Identified, Clinical Trials Underway, Hope on the Horizon
After years of mystery, researchers have identified key biological mechanisms driving Long COVID — viral persistence, autoimmunity, microbiome disruption, and mitochondrial dysfunction. Trials are now testing targeted therapies.
May 10, 2026
Cardiovascular Prevention in 2025: Beyond Statins — New Therapies and Emerging Targets
Statins reduced cardiovascular mortality 25–30% but significant residual risk remains. Inclisiran, PCSK9 inhibitors, icosapentaenoic acid, and inflammation-targeted therapies are changing secondary prevention.
May 8, 2026
Lymphedema Management: Complete Decongestive Therapy, Compression & Clinical Protocols
Lymphedema affects 5–6 million Americans, predominantly post-cancer treatment. CDT (complete decongestive therapy) is the evidence-based standard. This guide covers assessment, treatment, and supplies.
May 8, 2026
Pharmacogenomics in Clinical Practice: Right Drug, Right Dose, Right Patient
Genetic variation explains 20–95% of interindividual differences in drug response. Pharmacogenomic testing is entering routine clinical practice, preventing adverse drug reactions and treatment failures.
May 8, 2026
Wound Healing Biology in 2025: From Acute Phases to Chronic Wound Molecular Pathology
Understanding the molecular biology of wound healing — and what goes wrong in chronic wounds — guides selection of advanced wound care products. Here's the current science.
May 4, 2026
Hospital Delirium Prevention: ABCDEF Bundle, ICU Protocols & Clinical Supply Requirements
Delirium affects 20–80% of ICU patients and independently predicts mortality, functional decline, and long-term cognitive impairment. The ABCDEF bundle reduces delirium by up to 68%.
May 4, 2026
Diabetes Technology in 2025: CGM, Closed-Loop Systems & Digital Health Integration
Continuous glucose monitors, automated insulin delivery systems, and smart pen technology have transformed diabetes management. This guide covers the evidence and supply requirements.
Apr 30, 2026
PCSK9 Inhibitors: The New Standard for High-Risk Cardiovascular Patients Who Can't Get Low Enough on Statins
PCSK9 inhibitors reduce LDL-C by 50–70% on top of statins and cut major cardiovascular events by 15–20%. With biosimilars now lowering cost, their use is expanding rapidly.
Apr 28, 2026
Clinical Nutrition in Oncology: Malnutrition, Cachexia & Feeding the Cancer Patient
Malnutrition affects 40–80% of cancer patients and independently predicts survival. This guide covers evidence-based nutrition support strategies, cachexia management, and appropriate product selection.
Apr 26, 2026
Antibiotic Stewardship in 2025: Combating Resistance Through Rational Prescribing
Antimicrobial resistance kills 700,000 people annually — projected to reach 10 million by 2050. This guide covers antibiotic stewardship principles, rapid diagnostics, and clinical protocols.
Apr 22, 2026
Remote Patient Monitoring in Clinical Practice: What to Monitor, How to Implement, What the Evidence Shows
RPM programs using connected devices for blood pressure, glucose, weight, and SpO2 are showing 15–30% reductions in hospitalization. CMS billing codes have made them financially sustainable for most practices.
Apr 22, 2026
Stroke Prevention in 2025: AF Anticoagulation, Hypertension Control, and Updated Risk Stratification
Evidence-based clinical guide to stroke prevention — CHA₂DS₂-VASc scoring for AFib anticoagulation, blood pressure targets, carotid stenosis management, and PCSK9 inhibitor role in high-risk patients.
Apr 20, 2026
Multimodal Pain Management in 2025: Opioid-Sparing Strategies and Evidence-Based Protocols
The opioid crisis has driven development of opioid-sparing multimodal analgesia protocols. This guide covers regional anesthesia, non-opioid pharmacology, and supply requirements for enhanced recovery programs.
Apr 18, 2026
Biosimilars in Clinical Practice 2025: Adoption, Interchangeability & Formulary Decisions
FDA has approved 70+ biosimilars, but real-world adoption remains below potential. This guide helps clinicians and pharmacy directors understand interchangeability, nocebo effects, and formulary strategy.
Apr 18, 2026
Colon Cancer Screening in 2025: Colonoscopy vs. Cologuard vs. Blood Tests — Which Should Patients Choose?
Colorectal cancer is 90% preventable with appropriate screening — yet 30% of eligible Americans are not up to date. New options including Cologuard, blood-based tests, and CT colonography are expanding the menu.
Apr 18, 2026
Menopause Hormone Therapy in 2025: The Evidence Reversal and Current Clinical Recommendations
Clinical review of menopausal hormone therapy — what the WHI study got wrong, the re-analysis evidence for younger menopausal women, the risk-benefit calculation, and current NAMS and ACOG recommendations.
Apr 17, 2026
Vitamin D Deficiency: Clinical Screening, Supplementation, and What the Evidence Really Shows
Comprehensive clinical guide to vitamin D deficiency — prevalence, optimal testing, supplementation protocols, and updated evidence on bone, immune, cardiovascular, and mental health outcomes.
Apr 15, 2026
Fall Prevention Programs for Elderly Patients: Evidence, Protocols & Supply Requirements
Falls are the leading cause of injury death in adults over 65. Effective fall prevention programs address multiple risk factors simultaneously. Here's the evidence and supply infrastructure required.
Apr 14, 2026
IBD Biologics in 2025: Comparing Infliximab, Vedolizumab, Ustekinumab, and the New JAK Inhibitors
Evidence-based guide to biologic and small-molecule therapy for Crohn's disease and ulcerative colitis — head-to-head data, positioning strategies, and biosimilar considerations in 2025.
Apr 12, 2026
Surgical Robotics in 2025: Clinical Evidence, Outcomes Data & Supply Implications
Robotic surgery has grown to 1.5 million procedures annually in the U.S. The evidence on outcomes vs. laparoscopic surgery is now mature. Here's what the clinical data shows.
Apr 10, 2026
Pediatric Obesity in 2025: Prevention, Clinical Management & the Role of GLP-1 Medications
Pediatric obesity affects 20% of U.S. children. The AAP's 2023 Clinical Practice Guideline recommends intensive intervention including pharmacotherapy and surgery for appropriate patients.
Apr 10, 2026
Genomics and Precision Medicine in Clinical Practice: What's Ready for Prime Time in 2025
Whole genome sequencing costs have dropped below $200. Pharmacogenomics, polygenic risk scores, and hereditary cancer testing are now routine clinical tools. Here's what clinicians need to know.
Apr 6, 2026
Hydrogel Wound Dressings: Clinical Applications, Evidence & Selection Guide
Hydrogels donate moisture to dry wounds and rehydrate necrotic tissue — the opposite of absorbent foam dressings. This guide covers when hydrogels are appropriate and the evidence for advanced hydrogel formulations.
Apr 6, 2026
Concierge Medicine vs. Direct Primary Care: Models, Evidence, and Clinical Supply Implications
Comparison of DPC and concierge medicine models — how they differ, the evidence on patient outcomes and physician burnout, and what these growing models mean for medical supply procurement.
Apr 4, 2026
Newborn Screening & Early Intervention: The Clinical and Supply Infrastructure for 2025
Universal newborn screening identifies 12,000+ metabolic and genetic disorders annually before symptoms appear. This guide covers screening programs, follow-up protocols, and clinical supply requirements.
Apr 2, 2026
Cardiac Monitoring in 2025: Telemetry, Ambulatory ECG & Wearable Cardiac Monitors
The cardiac monitoring landscape has expanded from Holter monitors to 30-day patch monitors to implantable loop recorders. This guide helps clinicians match monitoring strategy to clinical indication.
Apr 2, 2026
Nasal Airway Optimization: Rhinitis, Nasal Polyps, and Breathing-Related Sleep Disorders in 2025
Clinical guide to nasal airway conditions — allergic vs. non-allergic rhinitis differentiation, intranasal steroid evidence, nasal polyp treatment (dupilumab evidence), and the connection between nasal airway and sleep quality.
Apr 1, 2026
AI Clinical Decision Support in Nursing Practice: Tools, Evidence & Safe Implementation
AI tools in clinical nursing — early warning scores, sepsis alerts, medication safety checks — are rapidly becoming standard. This guide covers evidence, implementation challenges, and nursing implications.
Mar 29, 2026
Liquid Biopsy in Oncology 2025: ctDNA, Minimal Residual Disease & Cancer Early Detection
Liquid biopsy — detecting cancer-derived DNA, RNA, or proteins in blood — is transforming oncology staging, treatment monitoring, and cancer early detection. Here's the clinical evidence landscape.
Mar 29, 2026
Testosterone Replacement Therapy: Who Needs It, Risks, and Evidence in 2025
Evidence-based clinical review of testosterone replacement therapy — diagnosis of hypogonadism, treatment options, cardiovascular safety data, and monitoring protocols for prescribers.
Mar 28, 2026
Long COVID Management in 2025: Clinical Phenotypes, Evidence-Based Interventions & Support
Post-COVID condition affects 10–30% of COVID-19 survivors. This clinical guide covers the recognized phenotypes, diagnostic approach, evidence-based management, and rehabilitation supply requirements.
Mar 25, 2026
Hospital Infection Control: MRSA and C. diff Prevention — Evidence-Based Protocols in 2025
Clinical guide to HCAP prevention — evidence for MRSA decolonization (REDUCE MRSA trial), universal vs. targeted precautions, C. diff prevention through antibiotic stewardship and environmental cleaning, and bundle implementation.
Mar 24, 2026
Medical Supply Bulk Purchasing Strategies for Hospitals & LTC Facilities: A 2025 Guide
Bulk purchasing, GPO contracts, and vendor-managed inventory can reduce supply costs by 20–35%. This guide provides a practical framework for healthcare facility supply chain optimization.
Mar 17, 2026
Heat Illness: Heat Exhaustion vs. Heat Stroke — Emergency Recognition and Treatment in Clinical Settings
Clinical emergency guide to heat illness — the spectrum from heat cramps to exertional heat stroke, rapid recognition, the aggressive cooling imperative, and hospital management of severe heat stroke.
Mar 16, 2026
Opioid Risk Assessment and Safe Prescribing: CDC 2022 Guidelines and Clinical Implementation
Clinical guide to opioid prescribing safety — the 2022 CDC Clinical Practice Guideline, risk stratification tools (ORT, DIRE), PDMP requirements, naloxone co-prescribing evidence, and urine drug screening protocols.
Mar 16, 2026
The mRNA Vaccine Platform: What Comes After COVID
mRNA technology proved itself during the pandemic and is now being applied far beyond COVID. The expanding pipeline of mRNA vaccines in development.
Mar 11, 2026
Testosterone Replacement Therapy: Updated Evidence, Screening, and Management in 2025
Clinical guide to testosterone replacement therapy — the TRAVERSE cardiovascular safety trial results, diagnosis criteria, formulation comparison, and monitoring for men with hypogonadism.
Mar 8, 2026
Telehealth in 2025: Evidence for Clinical Outcomes, Policy Changes, and Best-Practice Implementation
Evidence-based review of telehealth — clinical outcome evidence by specialty, the post-pandemic policy landscape, audio-only telehealth equity considerations, and implementation best practices for clinical programs.
Mar 8, 2026
Vaccine Manufacturing Innovation: How Production Advances Are Improving Global Access
New manufacturing technologies are making vaccines faster and cheaper to produce at scale. How this could improve global vaccine equity and pandemic preparedness.
Mar 5, 2026
The Rare Disease Diagnostic Odyssey: Why Answers Take So Long to Find
Patients with rare diseases often wait years and see numerous specialists before diagnosis. Understanding the systemic reasons behind this diagnostic odyssey.
Mar 4, 2026
Medical Simulation Training in 2025: High-Fidelity Mannequins, VR, and Clinical Skills Outcomes
Evidence-based review of medical simulation for procedural skills training — laparoscopic simulators, IV access trainers, CPR mannequins, and what RCTs show about transfer of simulation skills to clinical outcomes.
Mar 2, 2026
Orphan Drug Development: The Economics and Ethics of Treating Rare Conditions
Developing treatments for rare diseases faces unique economic challenges given small patient populations. How policy and innovation are addressing this gap.
Mar 2, 2026
Genetic Counseling: The Essential Guide Through Complex Rare Disease Information
Genetic counselors help patients and families navigate the complex implications of rare disease diagnoses. Understanding this crucial but underutilized role.
Feb 28, 2026
The Autoimmune Diagnosis Delay: Why Patients Wait Years for Answers
Autoimmune conditions often take years to diagnose correctly, with patients cycling through misdiagnoses. Understanding why and what is changing.
Feb 27, 2026
Telehealth for Specialty Care: Closing the Access Gap in Rural and Underserved Areas
Specialist shortages leave many areas without timely access to expert care. How telehealth is bridging this gap for cardiology, dermatology, and beyond.
Feb 27, 2026
AI in Radiology: How Accurate Is Machine Learning at Reading Medical Images?
AI systems increasingly assist radiologists in interpreting scans. The evidence on where these tools genuinely improve accuracy and where limitations remain.
Feb 27, 2026
How Rare Disease Patient Advocacy Groups Drive Research and Treatment Progress
Patient advocacy organizations have become powerful drivers of rare disease research funding and treatment development. Their often-underappreciated role.
Feb 26, 2026
JAK Inhibitors: The Oral Medications Transforming Autoimmune Disease Treatment
Janus kinase inhibitors offer effective oral treatment for multiple autoimmune conditions. How they work and the safety considerations shaping their use.
Feb 25, 2026
Remote Patient Monitoring: How Continuous Data Is Changing Chronic Disease Management
Connected devices now transmit health data directly to care teams between appointments. The evidence behind remote monitoring for chronic conditions.
Feb 25, 2026
AI Medical Scribes: Reducing Documentation Burden and Physician Burnout
AI-powered ambient documentation tools are freeing clinicians from excessive charting time. How this technology addresses a major driver of burnout.
Feb 25, 2026
Diet and Autoimmune Disease: What the Evidence Actually Supports
Elimination diets are widely promoted for autoimmune conditions. Separating genuine dietary evidence from unproven claims in autoimmune disease management.
Feb 23, 2026
AI Diagnostic Bias: Why Medical AI Can Perform Worse for Underrepresented Patients
AI diagnostic tools can inherit and amplify biases from their training data. Understanding this equity challenge and efforts to address it.
Feb 23, 2026
Thyroid Disease Management in 2025: Updated Testing, Treatment Targets, and Subclinical Disease Evidence
Evidence-based clinical guide to hypothyroidism and hyperthyroidism — TSH targets, T3/T4 combination therapy debate, subclinical thyroid disease treatment thresholds, and Graves disease management.
Feb 22, 2026
Hybrid Care Models: Why the Future of Healthcare Blends Virtual and In-Person
Rather than replacing in-person care, telehealth is settling into hybrid models. How healthcare systems are designing care that combines both effectively.
Feb 21, 2026
AI in Drug Discovery: How Machine Learning Is Accelerating New Treatment Development
Drug discovery traditionally takes over a decade. AI is compressing key steps in this process, from target identification to molecule design.
Feb 21, 2026
Pediatric Emergency Recognition: Sepsis, Dehydration, and Respiratory Distress Assessment in 2025
Clinical guide to pediatric emergency recognition — the PEWS system for early deterioration detection, pediatric sepsis criteria (Phoenix Score), dehydration assessment scales, and respiratory distress danger signs.
Feb 20, 2026
Whole Genome Sequencing Enters the Clinic: What It Can and Cannot Yet Tell You
Sequencing costs have plummeted, bringing whole genome testing into clinical practice. Understanding its genuine diagnostic power and current limitations.
Feb 20, 2026
AI-Powered Retinal Imaging: How Automated Screening Is Catching Eye Disease Earlier
Artificial intelligence can now analyze retinal images to detect diabetic eye disease and other conditions automatically. How this technology is expanding access.
Feb 19, 2026
Telehealth Prescribing Rules: Navigating the Complex Regulatory Landscape
Prescribing medications via telehealth involves a patchwork of evolving regulations. Understanding the current landscape and its implications for patients.
Feb 19, 2026
Clinical Decision Support AI: Understanding Its Role and Its Real Limits
AI tools increasingly suggest diagnoses and treatments to clinicians. Understanding what these systems reliably contribute and why human judgment remains essential.
Feb 19, 2026
Pharmacogenomic Testing: Matching Medications to Your Genetic Profile for Safety
Genetic variants affect how individuals metabolize common medications. How pharmacogenomic testing is preventing adverse drug reactions and treatment failures.
Feb 18, 2026
Polygenic Risk Scores: Predicting Disease Risk From Hundreds of Genetic Variants
Unlike single-gene tests, polygenic risk scores combine many genetic variants to estimate disease risk. What they can offer and their significant current limitations.
Feb 16, 2026
NP Full Practice Authority in 2025: States, Scope, and What It Means for Clinical Supply Procurement
Updated state-by-state review of nurse practitioner full practice authority, what expanded NP autonomy means for healthcare delivery, and supply procurement implications for NP-led practices.
Feb 14, 2026
Epigenetic Clocks: How Scientists Measure Your Biological Age
Epigenetic clocks estimate biological age from DNA methylation patterns. What these tests measure, what they predict, and their real limitations.
Feb 14, 2026
Gene Therapy for Rare Diseases: A New Treatment Paradigm Reaches More Patients
Gene therapies are increasingly approved for rare genetic conditions once considered untreatable. How this treatment approach is expanding and its challenges.
Feb 14, 2026
Senolytics: The Drugs Targeting Aging Cells to Extend Healthspan
Senescent cells accumulate with age and drive disease. Senolytic drugs that clear them are among the most promising anti-aging approaches in trials.
Feb 12, 2026
Direct-to-Consumer Genetic Testing: What Your Results Can and Cannot Reliably Tell You
Consumer genetic tests are popular but their health predictions have real limitations. Understanding what these tests reliably show versus what requires clinical confirmation.
Feb 12, 2026
IV Vitamin Drips: Evidence-Based Review of Benefits, Risks, and Clinical Appropriateness
Evidence-based review of IV vitamin therapy and vitamin drip services — clinical indications where IV nutrients are appropriate, evidence against IV vitamin therapy for wellness, and the risks of unregulated IV lounge services.
Feb 11, 2026
Osteoporosis and Fracture Prevention: Updated Evidence for Screening, Pharmacotherapy, and Fall Prevention
Clinical guide to osteoporosis management — DEXA screening indications, FRAX fracture risk calculation, comparative evidence for bisphosphonates vs. denosumab vs. romosozumab, and fall prevention program evidence.
Feb 11, 2026
NAD+ and Aging: Separating the Longevity Science From the Supplement Hype
NAD+ decline is linked to aging, spawning a booming supplement market. What the evidence actually supports about boosting this crucial molecule.
Feb 10, 2026
How Lifestyle Rewrites Your Genes: The Practical Science of Epigenetics
Diet, exercise, stress, and sleep influence which genes are active through epigenetic mechanisms. The practical implications of this gene-environment dialogue.
Feb 8, 2026
Inside Longevity Clinics: What They Offer and What the Evidence Supports
Longevity clinics offer testing, supplements, and interventions to slow aging. A critical look at which services have evidence and which are premium speculation.
Feb 6, 2026
Pediatric Asthma in 2025: Updated NAEPP Guidelines, Biologics, and School-Based Management
Evidence-based update on pediatric asthma management — NAEPP 2020 stepwise care, dupilumab and mepolizumab for severe pediatric asthma, and school-based asthma program evidence.
Feb 5, 2026
CRISPR Gene Editing Reaches the Clinic: The First Approved Therapies and What Comes Next
Gene editing has moved from laboratory promise to approved therapy. Explore the first CRISPR treatments, how they work, and the frontier of genetic medicine.
Jan 29, 2026
Nurse Staffing Ratios and Patient Outcomes: What the Evidence Shows in 2025
Evidence review of nurse-to-patient staffing ratios — mortality data, harm event rates, the California mandate experience, and the nursing shortage driving staffing policy debates in 2025.
Jan 27, 2026
mRNA Technology Beyond COVID: The Platform Transforming Vaccines and Medicine
mRNA vaccines proved themselves during the pandemic. Now the platform is being applied to cancer, rare diseases, and infections that long resisted vaccines.
Jan 23, 2026
Sleep Apnea Treatment in 2025: Beyond CPAP — Inspire, Oral Appliances, and Positional Therapy
Evidence-based guide to OSA treatment alternatives — Inspire hypoglossal nerve stimulation, mandibular advancement devices, positional therapy, and when alternatives to CPAP are appropriate.
Jan 19, 2026
Medical Waste Management: Regulatory Compliance, Best Practices, and Sharps Safety in 2025
Comprehensive guide to healthcare facility medical waste management — OSHA bloodborne pathogens standard, sharps safety, regulated medical waste classifications, and disposal compliance for clinical facilities.
Jan 18, 2026
Chronic Pain Management Without Opioids: Evidence-Based Alternatives in 2025
Comprehensive clinical guide to non-opioid chronic pain management — evidence for physical therapy, cognitive behavioral therapy, neuromodulation, SNRIs, pregabalin, and integrative approaches including acupuncture.
Jan 16, 2026
Artificial Intelligence in Medical Diagnosis: Where It Helps and Where to Be Cautious
AI diagnostic tools are entering clinical practice across specialties. Explore where machine learning genuinely improves diagnosis and the important caveats.
Jan 15, 2026
Reducing Hospital Readmissions in 2025: Transitional Care Models and High-Risk Patient Strategies
Evidence-based guide to reducing 30-day readmissions — HRRP penalties, transitional care programs, medication reconciliation, and discharge planning strategies that work for CHF, COPD, and pneumonia.
Jan 11, 2026
Wearable Health Technology: From Consumer Gadgets to Clinical Tools
Wearables now detect atrial fibrillation, track sleep, and monitor chronic disease. Explore how consumer devices are becoming legitimate clinical instruments.
Jan 7, 2026
Teledermatology and AI Skin Analysis in 2025: Clinical Accuracy, Access, and Reimbursement
Evidence-based review of teledermatology — store-and-forward vs. live video modalities, AI melanoma detection accuracy, rural access improvement data, and Medicare/Medicaid reimbursement landscape.
Jan 3, 2026
Liquid Biopsy: Detecting Cancer Through a Simple Blood Test
Liquid biopsy can detect cancer DNA circulating in blood, promising earlier detection and better monitoring. Explore the science and current state of this technology.
Dec 31, 2025
3D Printing in Medicine: Custom Implants, Anatomical Models, and Bioprinting
Three-dimensional printing is enabling personalized implants, surgical planning models, and even printed tissue. Explore the current and future medical applications.
Dec 23, 2025
Medication Error Prevention in 2025: Technology, Protocols, and the Human Factors Approach
Evidence-based guide to reducing medication errors in hospital settings — CPOE, barcode medication administration, smart infusion pumps, pharmacist interventions, and the systems-based safety approach.
Dec 18, 2025
Ketamine Therapy for Treatment-Resistant Depression: Clinical Evidence and Protocol in 2025
Evidence-based clinical review of IV ketamine and esketamine (Spravato) for treatment-resistant depression — mechanism, evidence from RCTs, patient selection, risks, and real-world outcomes.
Dec 15, 2025
Telemedicine After the Boom: What Sticks and What Reverts
The pandemic drove explosive telemedicine adoption. Now the field is settling into a durable role. Explore where virtual care genuinely excels and its limits.
Dec 15, 2025
Microbiome Therapeutics: From Fecal Transplants to Designed Bacterial Medicines
Manipulating the gut microbiome is becoming real medicine. Explore fecal transplants, the first approved microbiome drugs, and the future of bacterial therapeutics.
Dec 5, 2025
Bioelectronic Medicine: Treating Disease With Electricity Instead of Drugs
Bioelectronic medicine uses precise electrical stimulation of nerves to treat conditions from epilepsy to inflammation. Explore this convergence of neuroscience and engineering.
Nov 29, 2025
Regenerative Medicine: The Real Science of Stem Cells and Tissue Repair
Regenerative medicine promises to repair damaged tissue and organs. We separate the genuine advances from the unproven stem cell clinics exploiting the hype.
Nov 23, 2025
Precision Medicine and Pharmacogenomics: Matching Treatment to Your Genes
Your genes influence how you respond to medications. Explore how pharmacogenomics is personalizing prescriptions and reducing adverse drug reactions.
Nov 17, 2025
Digital Therapeutics: When Software Becomes Medicine
Prescription digital therapeutics deliver evidence-based treatment through software. Explore this emerging category of clinically validated apps and their role in care.
Nov 11, 2025
Organ-on-a-Chip: Miniature Human Organs Transforming Drug Development
Organ-on-a-chip technology recreates human organ function on microchips, promising better drug testing and less animal experimentation. Explore this bioengineering frontier.
Nov 5, 2025
Nanomedicine: How Tiny Particles Are Revolutionizing Drug Delivery
Nanotechnology enables drugs to target disease precisely while sparing healthy tissue. Explore how nanomedicine is improving treatment across cancer and beyond.
Oct 30, 2025
Point-of-Care Diagnostics: Bringing the Lab to the Patient
Rapid diagnostic tests are moving testing from centralized labs to the bedside, pharmacy, and home. Explore how point-of-care diagnostics is decentralizing medicine.
Oct 24, 2025
Nitrile vs. Latex Gloves: The Complete Healthcare Worker's Guide
Choosing the wrong exam glove puts patients and staff at risk. This evidence-based guide breaks down tensile strength, allergy data, chemical resistance, and FDA standards to help you make the right call.
Jul 1, 2025
Wound Care Dressing Selection: Matching the Right Product to Every Wound Type
Hydrocolloids, foams, alginates, silver dressings, and negative pressure therapy all have distinct indications. This clinical guide helps wound care nurses and procurement teams match dressings to wound characteristics.
Jun 28, 2025
Pressure Injury Prevention in Long-Term Care: Protocols, Products & CMS Requirements
Hospital-acquired pressure injuries cost U.S. healthcare $26.8 billion annually. Here's the evidence-based prevention protocol — including NPUAP staging, risk assessment tools, and the supply categories that matter most.
Jun 25, 2025
N95, KN95, or Surgical Mask? The Definitive PPE Selection Guide for Healthcare Settings
NIOSH-approved N95 respirators, ASTM-rated surgical masks, and KN95 alternatives each offer different protection levels. This evidence-based guide helps infection control teams select the right respiratory protection.
Jun 22, 2025
IV Catheter Care: Evidence-Based Protocols to Prevent Phlebitis and Bloodstream Infections
Central line-associated bloodstream infections (CLABSIs) kill 28,000 Americans annually. This guide covers evidence-based bundle elements, dressing protocols, and the supply products that reduce infection rates.
Jun 19, 2025
Incontinence Management in Skilled Nursing Facilities: Products, Protocols & Staff Training
Incontinence affects over 50% of SNF residents and is the leading cause of skin breakdown. This comprehensive guide covers containment products, prompted voiding programs, and supply optimization strategies.
Jun 16, 2025
Ostomy Care: A Complete Clinical Guide for Colostomy, Ileostomy & Urostomy Management
Over 750,000 Americans live with an ostomy. This guide covers peristomal skin assessment, pouching system selection, irrigation protocols, and the supply categories that support optimal ostomy outcomes.
Jun 13, 2025
Respiratory Therapy Equipment Guide for SNFs and Hospitals: Oxygen, Nebulizers & Ventilators
Selecting and maintaining respiratory equipment — from stationary oxygen concentrators to portable nebulizers to home mechanical ventilators — requires clinical and supply chain expertise this guide provides.
Jun 10, 2025
Medical Nutrition Therapy for Critically Ill Patients: ICU Enteral & Parenteral Nutrition Guide
Early enteral nutrition within 24–48 hours of ICU admission improves outcomes and reduces hospital length of stay. This guide covers ICU nutrition protocols, tube feeding products, and PN management.
Jun 7, 2025
Lab Specimen Collection Best Practices: Phlebotomy, Specimen Integrity & Tube Selection Guide
Pre-analytical errors — wrong tube, improper mixing, delayed transport — cause 60–70% of laboratory errors. This guide covers venipuncture technique, tube selection by test, and specimen handling protocols.
Jun 4, 2025
Surgical Site Infection Prevention: OR Supply Protocols That Actually Reduce SSI Rates
SSIs occur in 2–5% of all surgeries and cost $3.5 billion annually in the U.S. This guide covers the evidence-based prevention bundle, draping protocols, and the OR supplies that make a measurable difference.
Jun 1, 2025
Diabetic Foot Ulcer Management in 2025: From Offloading to Bioengineered Skin
Diabetic foot ulcers precede 85% of lower-extremity amputations. This guide covers evidence-based wound bed preparation, offloading, vascular assessment, and advanced wound products for DFU management.
May 28, 2025
Compression Therapy for Venous Insufficiency & Lymphedema: Products, Protocols & Evidence
Compression bandaging and hosiery are the cornerstone of venous leg ulcer and lymphedema management. This guide covers compression classes, multi-layer systems, and the clinical evidence behind each product type.
May 24, 2025
Dental Infection Control: PPE, Sterilization Standards & Supply Management for 2025
OSHA Bloodborne Pathogen Standard and CDC dental infection control guidelines mandate specific PPE, sterilization protocols, and surface disinfection procedures. This guide covers every supply requirement.
May 21, 2025
Pediatric Medical Supply Guide: Size, Dosing & Equipment Considerations for Infants to Adolescents
Pediatric patients aren't small adults. Equipment sizing, drug dosing, and supply selection require age-specific knowledge from neonatal through adolescent care. This guide covers every key pediatric supply category.
May 18, 2025
Medical Textiles in Healthcare: Standards, Selection & Infection Control for Hospital Linens and Gowns
Hospital textiles — gowns, drapes, linens, and OR attire — must meet AAMI, AORN, and OSHA standards. This guide covers barrier performance levels, laundering requirements, and supply management for healthcare textiles.
May 15, 2025
Durable Medical Equipment (DME) Guide for Long-Term Care & Home Health: Coverage, Selection & Suppliers
Wheelchairs, walkers, hospital beds, and CPAP devices fall under the DME benefit — but coverage requirements, functional criteria, and equipment selection vary widely. This guide covers everything procurement teams need to know.
May 12, 2025
Hospital-Acquired Infection Prevention: The Complete HAI Bundle Guide for 2025
CLABSIs, CAUTIs, VAP, MRSA, and C. diff collectively affect 1 in 31 hospitalized patients. This guide covers the evidence-based prevention bundle for each HAI type with supply requirements.
May 9, 2025
Hospital Pharmacy Supply Guide: Unit Dose Dispensing, IV Admixture & Automation
The modern hospital pharmacy uses automated dispensing cabinets, IV robots, barcode verification, and unit-dose packaging to prevent medication errors. This guide covers the supply infrastructure behind pharmacy safety.
May 6, 2025
Hand Hygiene Science: Why Alcohol-Based Rubs Beat Soap in Healthcare (And When They Don't)
The WHO 5 Moments of Hand Hygiene framework and the scientific case for alcohol-based hand rubs over traditional handwashing — with the critical exceptions every clinician must know.
May 3, 2025
mRNA Technology Beyond COVID: The Next Wave of Vaccines and Therapies
The COVID-19 vaccines proved mRNA technology at scale. Now the platform is being deployed against cancer, HIV, influenza, heart disease, and rare genetic disorders — with breathtaking speed.
Apr 30, 2025
First Aid Kit Compliance for Healthcare & Commercial Settings: OSHA Requirements & Product Selection
OSHA 29 CFR 1910.151 requires employer-provided first aid supplies. This guide covers minimum required contents by workplace type, ANSI Z308.1 standards, and kit maintenance protocols.
Apr 30, 2025
Cold Chain Management for Medical Products: Temperature-Sensitive Supply Best Practices
Vaccines, biologics, insulin, and blood products require strict temperature control from manufacturer to patient. This guide covers cold chain equipment, monitoring, and regulatory requirements for healthcare facilities.
Apr 24, 2025
Reusable vs. Disposable Medical Devices: The Clinical, Environmental & Economic Analysis
Healthcare generates 6.2 million tons of waste annually. The reusable-vs-disposable decision involves clinical safety, carbon footprint, total lifecycle cost, and regulatory compliance — here's the evidence.
Apr 21, 2025
AI-Powered Hospital Supply Chain: How Machine Learning Is Transforming Medical Procurement
Predictive inventory management, automated purchase orders, and demand forecasting AI are reducing medical supply waste by 20–30% in early adopting health systems. Here's how it works.
Apr 18, 2025
AI in Diagnostic Imaging: How Machine Learning Is Reading Scans Better Than Radiologists
Deep learning algorithms trained on millions of annotated images are now matching — and in some applications exceeding — specialist radiologist accuracy. What this means for healthcare.
Apr 14, 2025
Personalized Medicine & Pharmacogenomics: Matching Drugs to Your DNA
Your genetic variants determine whether a drug will work, fail, or harm you. Pharmacogenomics is moving from research tool to clinical standard, with the potential to eliminate trial-and-error prescribing.
Jan 27, 2025Stock Your Facility with Clinical-Grade Supplies
1.5 Million+ FDA-cleared products. Bulk pricing for healthcare facilities nationwide.